Status:
COMPLETED
Reandron in Diabetic Men Witn Low Testosterone Level
Lead Sponsor:
Austin Health
Conditions:
Type 2 Diabetes
Hypogonadism
Eligibility:
MALE
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
In men with type 2 diabetes, low testosterone levels have been associated with insulin resistance, truncal obesity and symptoms such as fatigue and erectile dysfunction. Low testosterone may impair ca...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Testosterone less than 10 nmol/L
Exclusion
- Contraindication to
- Testosterone or
- IM injection
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00613782
Start Date
January 1 2009
End Date
April 1 2014
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Austin Health
Melbourne, Victoria, Australia, 3084